Features of Menstrual Disorders in Obese Women and Ways for Their Correction Using Orlistat
Journal Title: Міжнародний ендокринологічний журнал - Year 2014, Vol 5, Issue 61
Abstract
The research deals with the problem of reproductive health in women with obesity. In obese women, oligomenorrhea (in 62.2 % of examines patients) prevails in the structure of menstrual disorders. On the background of obesity, incidence of metabolic syndrome is 68.9 %, and impaired glucose tolerance — 35.6 %. Administration of Xenical® for six months enables to obtain menstrual function recovery in 75.6 % of women with obesity, and in 31.1 % — recovery of ovarian function.
Authors and Affiliations
O. S. Payenok, M. O. Kostiv
Keywords
Related Articles
- EP ID EP228644
- DOI -
- Views 91
- Downloads 0
Evaluating the efficiency of surgical treatment of ACTH-dependent Cushing’s syndrome in the early and late postoperative period
Background. Adrenocorticotropic hormone-dependent Cushing’s syndrome (ACTH-dependent CS) is a form of endogenous CS caused by abnormal production of ACTH, in 80 % of cases — due to ACTH oversecretion by a pituitary adeno...
Analysis of Subclinical Hyperthyroidism Influence on Parameters of Bone Metabolism
State of subclinical hypothyroidism can be considered as the optimal model for assessing the significance of thyroid stimulating hormone (TSH) for bone tissue in clinical practice. Objective: to make a comparative analys...
New Therapeutic Possibilities of Type 2 Diabetes Mellitus Management: Experience of Voglibose Application
Objective of the study — an estimation of efficiency of application and tolerability of new alpha-glucosidase inhibitor voglibose (Voxid) in the treatment of patients with type 2 diabetes mellitus (DM). Material and Meth...
Subclinical Hypercorticism: the Necessity of Diagnostic Search
Considering certain difficulties in subclinical hypercorticism diagnosis, the object of this work is to focus attention of doctors in different areas on the necessity of thorough examination of patients with pathological...
Alpha-Glucosidase Inhibitor Voglibose: New Options in the Treatment and Prevention of Diabetes Mellitus
.